Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lu, Jie ^a   Zhou, Yingqun ^a   Hu, Tianyuan ^b   Zhang, Hui ^b   Shen, Miao ^a   Cheng, Ping ^a   Dai, Weiqi ^a   Wang, Fan ^a   Chen, Kan ^a   Zhang, Yan ^a   Wang, Chengfeng ^a   Li, Jingjing ^a   Zheng, Yuanyuan ^a   Yang, Jing ^a   Zhu, Rong ^a   Wang, Jianrong ^a   Lu, Wenxia ^a   Zhang, Huawei ^a   Wang, Junshan ^a   Xia, Yujing ^a   De Assuncao, Thiago M ^c   Jalan Sakrikar, Nidhi ^c   Huebert, Robert C ^c   Zhou, Bin ^b   Guo, Chuanyong ^a   more..

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NOTCH RECEPTOR; YAP PROTEIN, RAT;

ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENETICS; HEPATOBILIARY SYSTEM; KNOCKOUT MOUSE; LIVER; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; STEM CELL; SURGERY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BILIARY TRACT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HEPATECTOMY; HEPATOCYTES; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; LIVER; LIVER REGENERATION; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84960449963     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22754     Document Type: Article

References (41)

1. Pollheimer, M. J., Fickert, P. & Stieger, B. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis. Molecular aspects of medicine 37, 35-56, doi: 10.1016/j.mam.2013.10.001 (2014).
2. Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. Hepatology 43, S45-53, doi: 10.1002/hep.20969 (2006).
3. Best, J. et al. Role of liver progenitors in liver regeneration. Hepatobiliary surgery and nutrition 4, 48-58, doi: 10.3978/j.issn.2304-3881.2015.01.16 (2015).
4. Mohammed, F. F. et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41, 857-867, doi: 10.1002/hep.20618 (2005).
5. Vig, P. et al. The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice. Hepatology 43, 316-324, doi: 10.1002/hep.21018 (2006).
6. Rountree, C. B. et al. A CD133-expressing murine liver oval cell population with bilineage potential. Stem cells 25, 2419-2429, doi: 10.1634/stemcells.2007-0176 (2007).
7. Miyajima, A., Tanaka, M. & Itoh, T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell stem cell 14, 561-574, doi: 10.1016/j.stem.2014.04.010 (2014).
8. Rodrigo-Torres, D. et al. The biliary epithelium gives rise to liver progenitor cells. Hepatology 60, 1367-1377, doi: 10.1002/hep.27078 (2014).
9. Schaub, J. R., Malato, Y., Gormond, C. & Willenbring, H. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell reports 8, 933-939, doi: 10.1016/j.celrep.2014.07.003 (2014).
10. + liver progenitors in mouse oval cell injury. Hepatology 60, 278-289, doi: 10.1002/hep.27084 (2014).
11. Yanger, K. et al. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell stem cell 15, 340-349, doi: 10.1016/j.stem.2014.06.003 (2014).
12. He, J., Lu, H., Zou, Q. & Luo, L. Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish. Gastroenterology 146, 789-800 e788, doi: 10.1053/j.gastro.2013.11.045 (2014).
13. Choi, T. Y., Ninov, N., Stainier, D. Y. & Shin, D. Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish. Gastroenterology 146, 776-788, doi: 10.1053/j.gastro.2013.10.019 (2014).
14. Artavanis-Tsakonas, S., Matsuno, K. & Fortini, M. E. Notch signaling. Science 268, 225-232 (1995).
15. Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233, doi: 10.1016/j.cell.2009.03.045 (2009).
16. Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature genetics 16, 243-251, doi: 10.1038/ng0797-243 (1997).
17. Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature genetics 16, 235-242, doi: 10.1038/ng0797-235 (1997).
18. McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. American journal of human genetics 79, 169-173, doi: 10.1086/505332 (2006).
19. Geisler, F. et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48, 607-616, doi: 10.1002/hep.22381 (2008).
20. Yu, H. C. et al. Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology 54, 979-988, doi: 10.1002/hep.24469 (2011).
21. Michalopoulos, G. K. Liver regeneration. Journal of cellular physiology 213, 286-300, doi: 10.1002/jcp.21172 (2007).
22. Gailhouste, L. Isolation and purification method of mouse fetal hepatoblasts. Methods in molecular biology 826, 33-47, doi: 10.1007/978-1-61779-468-1-4 (2012).
23. Wang, F. et al. Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PloS one 7, e50638, doi: 10.1371/journal.pone.0050638 (2012).
24. Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324-1338, doi: 10.1016/j.cell.2014.03.060 (2014).
25. Lesage, G. et al. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. Gastroenterology 111, 1633-1644 (1996).
26. Sparks, E. E. et al. Defects in hepatic Notch signaling result in disruption of the communicating intrahepatic bile duct network in mice. Dis Model Mech 4, 359-367, doi: 10.1242/dmm.005793 (2011).
27. Zhang, X. et al. Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes. Lab Invest, doi: 10.1038/labinvest.2015.149 (2015).
28. Ortica, S. et al. The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 28, 603-614, doi: 10.1096/fj.13-235903 (2014).
29. Yamamoto, S., Schulze, K. L. & Bellen, H. J. Introduction to Notch signaling. Methods in molecular biology 1187, 1-14, doi: 10.1007/978-1-4939-1139-4-1 (2014).
30. Jeliazkova, P. et al. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 57, 2469-2479, doi: 10.1002/hep.26254 (2013).
31. Yen, W. C. et al. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. Clinical cancer research: an official journal of the American Association for Cancer Research 18, 5374-5386, doi: 10.1158/1078-0432.CCR-12-0736 (2012).
32. Gasperini, P. et al. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer research 72, 1157-1169, doi: 10.1158/0008-5472.CAN-11-3067 (2012).
33. Vanderpool, C. et al. Genetic interactions between hepatocyte nuclear factor-6 and Notch signaling regulate mouse intrahepatic bile duct development in vivo. Hepatology 55, 233-243, doi: 10.1002/hep.24631 (2012).
34. Wang, L. et al. Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice. Hepatology 49, 268-277, doi: 10.1002/hep.22579 (2009).
35. Li, L. et al. JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome. PloS one 10, e0130355, doi: 10.1371/journal.pone.0130355 (2015).
36. Fiorotto, R. et al. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice. J Hepatol 59, 124-130, doi: 10.1016/j.jhep.2013.02.025 (2013).
37. Geisler, F. & Strazzabosco, M. Emerging roles of Notch signaling in liver disease. Hepatology 61, 382-392, doi: 10.1002/hep.27268 (2015).
38. Dianat, N. et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology 60, 700-714, doi: 10.1002/hep.27165 (2014).
39. De Assuncao, T. M. et al. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Lab Invest 95, 684-696, doi: 10.1038/labinvest.2015.51 (2015).
40. Sampaziotis, F. et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nature biotechnology 33, 845-852, doi: 10.1038/nbt.3275 (2015).
41. Ogawa, M. et al. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nature biotechnology 33, 853-861, doi: 10.1038/nbt.3294 (2015).